Health
Maternal deaths in US more than doubled over 2 decades: study
Maternal deaths across the U.S. more than doubled over the course of two decades, and the tragedy unfolded unequally. Black...
Read moreDetails
Abeona Therapeutics to launch gene therapy with $25M in fundraising
Abeona Therapeutics (Nasdaq: ABEO), a clinical-stage biopharmaceutical firm based in Cleveland, announced it has raised $25 million from "select existing...
Read moreDetails
Beyond the Byline: Medicaid redeterminations
Alex Kacik: At least 1.5 million Medicaid beneficiaries across 25 states have been disenrolled from the Medicaid program as of June....
Read moreDetails
Q&A: Elevance food as medicine director on nutrition’s role in health
Elevance Health has hired its first food as medicine director to advance its goal of addressing chronic conditions among 47...
Read moreDetails
PAHO Director meets with Brazilian President to discuss public health priorities
Brasilia, 5 July 2023 (PAHO/WHO) - The Director of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa, today met...
Read moreDetails
Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years
Not intended for U.S. and UK Media Berlin, June 29, 2023 – Bayer today announced the two-year (96 weeks) topline...
Read moreDetails
Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes
Not intended for U.S. and UK Media Berlin, June 22, 2023 – Bayer announced today the initiation of FINE-ONE, a...
Read moreDetails
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
Berlin, May 16, 2023 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...
Read moreDetails
Slow start to the year as expected
Group sales stable at 14.389 billion euros (Fx & portfolio adj. minus 1.1 percent)o Accelerated normalization in glyphosate business – good price...
Read moreDetails
Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion
10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News